Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients

NCT01655108 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Female Pattern Alopecia

Interventions

DRUG: Minoxidil
DRUG: Saline

Sponsor

Brasilia University Hospital